Hepatitis C News and Research

Latest Hepatitis C News and Research

New study reports long-term infectious disease trends in China after SARS outbreak

Following the severe acute respiratory syndrome (SARS) outbreak in 2003, China stepped up its prevention and control methods for all infectious diseases, and rates of infection have levelled off since 2009.

19 Apr 2017

Nanoparticle-programmed immune cells can slow progression of leukemia in mouse model

Researchers at Fred Hutchinson Cancer Research Center have developed biodegradable nanoparticles that can be used to genetically program immune cells to recognize and destroy cancer cells -- while the immune cells are still inside the body.

17 Apr 2017

Injection drug use linked to increase in immune activation, says researcher

The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system.

13 Apr 2017

Scientists solve structure of protein crucial to reproduction and spread of Zika virus

Zika virus is a mosquito-borne infectious disease linked to certain birth defects in infants in South and Central America and the United States.

11 Apr 2017

FDA grants approval for two drugs to treat hepatitis C virus in children

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.

7 Apr 2017

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

As the population of people living with HIV in the United States ages, the burden of cancer for these patients is expected to shift away from cancers linked to AIDS and toward malignancies that affect the general population, according to a new study led by a University of North Carolina at Chapel Hill researcher.

5 Apr 2017

Low and high birth weights linked to severity of liver disease in children

Researchers at University of California San Diego School of Medicine, with a cohort of clinical collaborators from across the United States, have demonstrated the impact of low and high birth weights in developing Non Alcoholic Fatty Liver Disease (NAFLD), a chronic disease that often leads to a need for organ transplantation.

4 Apr 2017

Australia has potential to eradicate hepatitis C in 10–15 years, says expert

Australia has the potential to eradicate hepatitis C in the next 10–15 years, according to Associate Professor Simone Strasser, gastroenterologist at Royal Prince Alfred Hospital in Sydney.

4 Apr 2017

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.

29 Mar 2017

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

All causes of the most common form of liver cancer, hepatocellular carcinoma, are not yet known, but the risk of getting it is increased by hepatitis B or C, cirrhosis, obesity, diabetes, a buildup of iron in the liver, or a family of toxins called aflatoxins produced by fungi on some types of food.

29 Mar 2017

FDA approves new therapy for adult patients with relapsing and primary progressive MS

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

29 Mar 2017

Researchers map key Zika virus protein to accelerate search for cure

A study published today shows how Indiana University scientists are speeding the path to new treatments for the Zika virus, an infectious disease linked to birth defects in infants in South and Central America and the United States.

28 Mar 2017

One-shot vaccine passes key preclinical test in newborn monkey models

Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.

24 Mar 2017

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy.

23 Mar 2017

Statin drugs may offer treatment option for chronic liver disease

Statin drugs are widely used to manage high cholesterol and reduce the risk of cardiovascular disease. But in a new review of more than 50 studies, researchers cite reductions in liver inflammation and improvements in other related factors as reasons why statins make good candidates for treating chronic liver disease.

23 Mar 2017

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Transmission of infections with HIV, hepatitis B, syphilis or rubella from mother to child before and during birth as well as in infancy still occur across Europe - despite existing prevention methods.

21 Mar 2017

Treatment with interferon may ease symptoms of Ebola patients

A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

21 Mar 2017

New TB/HIV co-infections flare-up by 40% over last five years across Europe

New data released today by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015.

20 Mar 2017

Northumbria University uses G:BOX Chemi XX6 multi-application imager in biomedical research

Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 is being used by scientists at Northumbria University for imaging chemiluminescent enzymes and other proteins on Western blots. This is contributing to rapidly providing researchers with accurate information on changes in protein in chronic conditions such as diabetes, heart disease and cancer.

From Syngene 17 Mar 2017

Study shows how mutations allow HCV to elude immune responses and vaccines

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide.

16 Mar 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

New study reports long-term infectious disease trends in China after SARS outbreak

Nanoparticle-programmed immune cells can slow progression of leukemia in mouse model

Injection drug use linked to increase in immune activation, says researcher

Scientists solve structure of protein crucial to reproduction and spread of Zika virus

FDA grants approval for two drugs to treat hepatitis C virus in children

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Low and high birth weights linked to severity of liver disease in children

Australia has potential to eradicate hepatitis C in 10–15 years, says expert

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

FDA approves new therapy for adult patients with relapsing and primary progressive MS

Researchers map key Zika virus protein to accelerate search for cure

One-shot vaccine passes key preclinical test in newborn monkey models

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

Statin drugs may offer treatment option for chronic liver disease

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Treatment with interferon may ease symptoms of Ebola patients

New TB/HIV co-infections flare-up by 40% over last five years across Europe

Northumbria University uses G:BOX Chemi XX6 multi-application imager in biomedical research

Study shows how mutations allow HCV to elude immune responses and vaccines

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Hepatitis C News and Research

Latest Hepatitis C News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in